qa_id stringlengths 27 27 | qa_group_id stringlengths 28 32 | qa_family stringclasses 3
values | subtask_type stringclasses 7
values | qa_subtype stringclasses 3
values | cluster_id stringclasses 42
values | language stringclasses 1
value | split stringclasses 1
value | question stringlengths 148 1.41k | answer stringlengths 718 10.8k | claim_ids listlengths 0 8 | paper_ids listlengths 1 5 | evidence_span_ids listlengths 0 7 | association_ids listlengths 0 4 | hypothesis_ids listlengths 0 4 | record_json stringlengths 4.37k 33.7k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
QA:9b3ea9fd9c91eaaa2ad63ca5 | QAG:111d3549bd63e782c9ca9680 | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "The selected proteins were investigated by immunohistochemistry in pretreatment biopsies of a group of stage II/III locally advanced rectal cancer patients with the aims to evaluate their association with pathological complete response"? Return the original wording wit... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:88f5403ba487df05879c956e","quotes":["The selected proteins were investigated by immunohistochemistry in pretreatm... | [
"CLM:88f5403ba487df05879c956e"
] | [
"PMCID:PMC8790137"
] | [
"SPAN:e1048478339f0adc0edf6fd9"
] | [] | [] | {"qa_id":"QA:9b3ea9fd9c91eaaa2ad63ca5","qa_group_id":"QAG:111d3549bd63e782c9ca9680","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"The selected proteins were investigated by immunohistochemistry in... |
QA:9dfc888272271683acbeeea1 | QAG:f1c5895c0add208f3371d013 | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "Expression of hypoxia-inducible factor 1α predicted clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:07be322c849104c652b7f818","quotes":["2011:31(5):1559–1565. 38. Shioya M, Takahashi T, Ishikawa H, Sakurai H, Ebar... | [
"CLM:07be322c849104c652b7f818"
] | [
"PMCID:PMC8790137"
] | [
"SPAN:a3d59b77ba5ac776c028989b"
] | [] | [] | {"qa_id":"QA:9dfc888272271683acbeeea1","qa_group_id":"QAG:f1c5895c0add208f3371d013","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"Expression of hypoxia-inducible factor 1α predicted clinical outco... |
QA:9e443a9e24bbded9cd68bdf3 | QAG:27d6e5ae9b63facb2e70a386 | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9668658? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9668658","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9668658"
] | [] | [] | [] | {"qa_id":"QA:9e443a9e24bbded9cd68bdf3","qa_group_id":"QAG:27d6e5ae9b63facb2e70a386","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9668658... |
QA:9e90bb672d2f2a53126c5bdb | QAG:1cc4975419993f874af2535c | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "A pathological complete response to neoadjuvant chemoradiotherapy, which is the absence of visible residual tumor cells, is commonly observed in a subset of 15% to 30% of locally advanced rectal cancer patients 3,4 , which was associated with longer overall survival an... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d495af2670de091daa76212d","quotes":["A pathological complete response to neoadjuvant chemoradiotherapy, which is ... | [
"CLM:d495af2670de091daa76212d"
] | [
"PMCID:PMC8790137"
] | [
"SPAN:5803b2908226c1c2328b1ad9"
] | [] | [] | {"qa_id":"QA:9e90bb672d2f2a53126c5bdb","qa_group_id":"QAG:1cc4975419993f874af2535c","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"A pathological complete response to neoadjuvant chemoradiotherapy,... |
QA:9f2c25140b246ed140f6cc82 | QAG:78c1390bde2a70c73af0a493 | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "Interestingly, it has been reported that, in the radio-resistant rectal cancer cells, most of the differently expressed genes was associated with cell-cell adhesion and regulation of epithelial cell differentiation ( 12 )"? Return the original wording with paper, Claim... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:822a658624da7a0db7af588d","quotes":["Interestingly, it has been reported that, in the radio-resistant rectal canc... | [
"CLM:822a658624da7a0db7af588d"
] | [
"PMCID:PMC9582124"
] | [
"SPAN:76ea294073d7f20803affdf8"
] | [] | [] | {"qa_id":"QA:9f2c25140b246ed140f6cc82","qa_group_id":"QAG:78c1390bde2a70c73af0a493","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"Interestingly, it has been reported that, in the radio-resistant r... |
QA:9f5f0c3a40bd57ca89dda49f | QAG:106f06350dd04c0b6231645b | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC10481913? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiabl... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC10481913","verdict":"no_released_traceable_claim","reason":"No... | [] | [
"PMCID:PMC10481913"
] | [] | [] | [] | {"qa_id":"QA:9f5f0c3a40bd57ca89dda49f","qa_group_id":"QAG:106f06350dd04c0b6231645b","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC1048191... |
QA:9febf4793bf826d7c4e51849 | QAG:4e8420ad25b674dea5662795 | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:34340196? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:34340196","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:34340196"
] | [] | [] | [] | {"qa_id":"QA:9febf4793bf826d7c4e51849","qa_group_id":"QAG:4e8420ad25b674dea5662795","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:34340196? E... |
QA:a5e3c12f5d06f5db4da1ab38 | QAG:26ace1a0ba28b27faa262d1a | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicted response to neoadjuvant therapy in rectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirem... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6508df4040170b4fad2c14fe","quotes":["20. Song M., Li S., Wang H., Hu K., Wang F., Teng H., et al. MRI radiomics i... | [
"CLM:6508df4040170b4fad2c14fe"
] | [
"PMCID:PMC9719068"
] | [
"SPAN:e26b5e7dca833bc5c4aecbee"
] | [] | [] | {"qa_id":"QA:a5e3c12f5d06f5db4da1ab38","qa_group_id":"QAG:26ace1a0ba28b27faa262d1a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"MRI radiomics independent of clinical baseline characteristics and... |
QA:b241cd901e1ff5c3a98a0cdf | QAG:a69cf8fbac33f02025f93817 | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "This study aims to evaluate multiple magnetic resonance imaging (MRI) sequence-based radiomics methods in evaluating therapeutic response to nCRT in patients with locally advanced rectal cancer (LARC)"? Return the original wording with paper, Claim, and Evidence Span r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:99bac197ebb77530bf360292","quotes":["This study aimed to investigate multiple magnetic resonance imaging (MRI) se... | [
"CLM:99bac197ebb77530bf360292"
] | [
"PMCID:PMC8136527"
] | [
"SPAN:8f9c74718332438459e0ccf0"
] | [] | [] | {"qa_id":"QA:b241cd901e1ff5c3a98a0cdf","qa_group_id":"QAG:a69cf8fbac33f02025f93817","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"This study aims to evaluate multiple magnetic resonance imaging (M... |
QA:ba558db369e06e3774c96926 | QAG:4ad491952c735d7ae289d1e6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "Moreover, low DHRS9 expression has been indicated to be correlated with poor prognosis in CRC patients, but those who received any anti-cancer therapy were excluded ( 14 )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated proven... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f0d556659316118ae7633222","quotes":["Moreover, low DHRS9 expression has been indicated to be correlated with poor... | [
"CLM:f0d556659316118ae7633222"
] | [
"PMCID:PMC9582124"
] | [
"SPAN:f777544cbc5ffd5e5540cbb4"
] | [] | [] | {"qa_id":"QA:ba558db369e06e3774c96926","qa_group_id":"QAG:4ad491952c735d7ae289d1e6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"Moreover, low DHRS9 expression has been indicated to be correlated... |
QA:be0f61cb24ce33e869c5d3bd | QAG:aaafb48364d132614790df01 | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "Patients who achieved a complete or near-complete response after finishing treatment were offered watch-and-wait (WW)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c1144c8e54dbcff3a4e57986","quotes":["Patients who achieved a complete or near-complete response after finishing t... | [
"CLM:c1144c8e54dbcff3a4e57986"
] | [
"PMCID:PMC11578087"
] | [
"SPAN:0766654b76cbbeb35ba30971",
"SPAN:11a4b28f33773b2d4497f38d"
] | [] | [] | {"qa_id":"QA:be0f61cb24ce33e869c5d3bd","qa_group_id":"QAG:aaafb48364d132614790df01","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"Patients who achieved a complete or near-complete response after f... |
QA:c3ab4cb94a659924c61c9adc | QAG:712375d57c283f3696d61d75 | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "Relevance Early results suggest that this novel treatment strategy led to downstaging to ypT0/T1 cN0 in the majority of selected patients with early rectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1820f9ff4272f919bf3bd661","quotes":["Relevance Early results suggest that this novel treatment strategy leads to ... | [
"CLM:1820f9ff4272f919bf3bd661"
] | [
"PMCID:PMC9839227"
] | [
"SPAN:2a03bb2865b8e4a3ade5967e"
] | [] | [] | {"qa_id":"QA:c3ab4cb94a659924c61c9adc","qa_group_id":"QAG:712375d57c283f3696d61d75","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"Relevance Early results suggest that this novel treatment strategy... |
QA:c5c1e5c5d51e2251fb1d58c7 | QAG:91c5bffc08985b7902a9b6ba | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "However, other studies showed that a higher rate of Ki-67-positive cells in treatment-naive locally advanced rectal cancer biopsies was associated with a greater incidence of pathological complete response 22,23"? Return the original wording with paper, Claim, and Evid... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d60f5ff085384bc60caaa309","quotes":["However, other studies showed that a higher rate of Ki-67-positive cells in ... | [
"CLM:d60f5ff085384bc60caaa309"
] | [
"PMCID:PMC8790137"
] | [
"SPAN:2aa568ff835e1b0f83938592"
] | [] | [] | {"qa_id":"QA:c5c1e5c5d51e2251fb1d58c7","qa_group_id":"QAG:91c5bffc08985b7902a9b6ba","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"However, other studies showed that a higher rate of Ki-67-positive... |
QA:c87c9afda3304ac8a47aa3ae | QAG:edd856d95fcf81f11ee97b1f | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC12836718? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiabl... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC12836718","verdict":"no_released_traceable_claim","reason":"No... | [] | [
"PMCID:PMC12836718"
] | [] | [] | [] | {"qa_id":"QA:c87c9afda3304ac8a47aa3ae","qa_group_id":"QAG:edd856d95fcf81f11ee97b1f","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC1283671... |
QA:c8b958a01edbacd34f40af4c | QAG:904d8dc592dae23488558f2e | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35133200? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:35133200","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:35133200"
] | [] | [] | [] | {"qa_id":"QA:c8b958a01edbacd34f40af4c","qa_group_id":"QAG:904d8dc592dae23488558f2e","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35133200? E... |
QA:c8d7eecaf29effbd3f6ebdca | QAG:d3b26626aadca560f6f9974c | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "The identification of early molecular markers predictive of neoadjuvant chemoradiotherapy outcome in locally advanced rectal cancer is under investigation with compelling interest, but results remain questionable and frequently conflicting"? Return the original wording... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:dbe90ba395706b34bee1b170","quotes":["The identification of early molecular markers predictive of neoadjuvant chem... | [
"CLM:dbe90ba395706b34bee1b170"
] | [
"PMCID:PMC8790137"
] | [
"SPAN:23c778cb305e6014df8df97d"
] | [] | [] | {"qa_id":"QA:c8d7eecaf29effbd3f6ebdca","qa_group_id":"QAG:d3b26626aadca560f6f9974c","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"The identification of early molecular markers predictive of neoadj... |
QA:d771ed720f2e86ae44374858 | QAG:57255b63da66044e85ac485b | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "Abstract This retrospective study aims to evaluate the generalizability of a promising state-of-the-art multitask deep learning (DL) model for predicting the response of locally advanced rectal cancer (LARC) to neoadjuvant chemoradiotherapy (nCRT) using a multicenter d... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:af1ad9518da6b4721daa5028","quotes":["Abstract This retrospective study aims to evaluate the generalizability of a... | [
"CLM:af1ad9518da6b4721daa5028"
] | [
"PMCID:PMC9317842"
] | [
"SPAN:50c5fd70a0d6e78d7c6f0e3b"
] | [] | [] | {"qa_id":"QA:d771ed720f2e86ae44374858","qa_group_id":"QAG:57255b63da66044e85ac485b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"Abstract This retrospective study aims to evaluate the generalizab... |
QA:dd8aac915ab2cc449d9106c1 | QAG:d81b6efce3feb29d964c3cdb | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9265129? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9265129","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9265129"
] | [] | [] | [] | {"qa_id":"QA:dd8aac915ab2cc449d9106c1","qa_group_id":"QAG:d81b6efce3feb29d964c3cdb","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9265129... |
QA:df8c63e9a79f552ee760a821 | QAG:8133d62f14cf311dcedcc876 | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "From March 2007 to September 2012, 186 patients with a low rectal cancer stage T2/T3 were enrolled at 15 French institutions and 148 clinically good responders were randomized resulting in 74 in the LE group and 74 in the TME group"? Return the original wording with pa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:505feb25a4d66f291a9ca6ae","quotes":["From March 2007 to September 2012, 186 patients with a low rectal cancer sta... | [
"CLM:505feb25a4d66f291a9ca6ae"
] | [
"PMCID:PMC8183183"
] | [
"SPAN:7f454e3f0659299c43ee1563"
] | [] | [] | {"qa_id":"QA:df8c63e9a79f552ee760a821","qa_group_id":"QAG:8133d62f14cf311dcedcc876","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"From March 2007 to September 2012, 186 patients with a low rectal ... |
QA:e2e1cc2cc4e7fcb7534d41a7 | QAG:2db0c83558dd50d439b63798 | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:33427960? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:33427960","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:33427960"
] | [] | [] | [] | {"qa_id":"QA:e2e1cc2cc4e7fcb7534d41a7","qa_group_id":"QAG:2db0c83558dd50d439b63798","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:33427960? E... |
QA:ec5a30c95d4a5eabbaee925d | QAG:58c0871803ab31fa6847262c | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "The standard of care for the clinical management of stage II/III locally advanced rectal cancer relies on neoadjuvant chemoradiotherapy treatment, followed by radical surgery including total mesorectal excision, optionally followed by an adjuvant chemotherapy, which wa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:01dd7e0d72c104c81a520ad9","quotes":["The standard of care for the clinical management of stage II/III locally adv... | [
"CLM:01dd7e0d72c104c81a520ad9"
] | [
"PMCID:PMC8790137"
] | [
"SPAN:4c76c4431e94e2c759a15ecb"
] | [] | [] | {"qa_id":"QA:ec5a30c95d4a5eabbaee925d","qa_group_id":"QAG:58c0871803ab31fa6847262c","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"The standard of care for the clinical management of stage II/III l... |
QA:eccc9bf2379e3f5ef827f6f7 | QAG:e030b945fb818c4e3b549dbc | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9311773? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9311773","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9311773"
] | [] | [] | [] | {"qa_id":"QA:eccc9bf2379e3f5ef827f6f7","qa_group_id":"QAG:e030b945fb818c4e3b549dbc","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9311773... |
QA:f13a7f2b7cc552566626abb5 | QAG:9538e50bb76128c43c9c0c9e | provenance_qa | exact_evidence_retrieval | provenance_qa | G016 | en | train | Which exact source passage supports the statement "cCR of 40% has been achieved with total neoadjuvant therapy"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span references; assess t... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:50e63bab6e5267497297f7bb","quotes":["Expert opinion : Our current ability to predict the response to chemoradioth... | [
"CLM:50e63bab6e5267497297f7bb"
] | [
"PMID:33356679"
] | [
"SPAN:0e0ae09f32886984d2486a41"
] | [] | [] | {"qa_id":"QA:f13a7f2b7cc552566626abb5","qa_group_id":"QAG:9538e50bb76128c43c9c0c9e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G016","question":"Which exact source passage supports the statement \"cCR of 40% has been achieved with total neoadjuvant therapy\"? Ret... |
QA:f2c0a2c2aa0c990a4b801c02 | QAG:63f2b613de4bc54897174129 | provenance_qa | paper_evidence_availability | provenance_qa | G016 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9362876? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9362876","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9362876"
] | [] | [] | [] | {"qa_id":"QA:f2c0a2c2aa0c990a4b801c02","qa_group_id":"QAG:63f2b613de4bc54897174129","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G016","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9362876... |
QA:025d2445783219dc60beb20c | QAG:4bd7505442156b0e47e1a5ea | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "To understand how CXCR2 inhibition causes a reduction in the KRAS (G12D) promoted growth potential of PDAC cells we evaluated the activation of the ERK pathway and total levels of KRAS"? Return the original wording with paper, Claim, and Evidence Span references.
Inte... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:92b63ada66f900437c3f53e9","quotes":["To understand how CXCR2 inhibition causes a reduction in the KRAS (G12D) -in... | [
"CLM:92b63ada66f900437c3f53e9",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC4872785"
] | [
"SPAN:9b3bf1cf088f56b41c93adcf"
] | [] | [] | {"qa_id":"QA:025d2445783219dc60beb20c","qa_group_id":"QAG:4bd7505442156b0e47e1a5ea","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"To understand how CXCR2 inhibition causes a reduction in the KRAS ... |
QA:0268ad8e30ac8bcac1cfb4bb | QAG:069d1b952f73b271dd9e4aed | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "In this report, we reveal a previously unidentified tumor cell-autonomous role of KRAS (G12D) promoted CXCR2 signaling in mediating growth of neoplastic PDAC cells"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance req... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a4aa10baf6e14a164e19c3a8","quotes":["In this report, we reveal a previously unidentified tumor cell-autonomous ro... | [
"CLM:a4aa10baf6e14a164e19c3a8",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC4872785"
] | [
"SPAN:45cbd6094eebd6a00f157798"
] | [] | [] | {"qa_id":"QA:0268ad8e30ac8bcac1cfb4bb","qa_group_id":"QAG:069d1b952f73b271dd9e4aed","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"In this report, we reveal a previously unidentified tumor cell-aut... |
QA:04fd7ef29be909a4ca92aab7 | QAG:2f6a1f543fa02e8717b64a52 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "72 Accordingly, we observed that THZ1 effectively inhibited the PI3K/AKT/mTOR pathway, which was significantly associated with CDK7 expression in PDAC, and the downstream molecules"? Return the original wording with paper, Claim, and Evidence Span references.
Integrat... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e19052813c80d9a1345c4cdf","quotes":["72 Accordingly, we observed that THZ1 effectively suppressed the PI3K/AKT/mT... | [
"CLM:e19052813c80d9a1345c4cdf",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10689978"
] | [
"SPAN:86769bda31076ed2f95e9d41"
] | [] | [] | {"qa_id":"QA:04fd7ef29be909a4ca92aab7","qa_group_id":"QAG:2f6a1f543fa02e8717b64a52","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"72 Accordingly, we observed that THZ1 effectively inhibited the PI... |
QA:0511e1f7eb5b8b54ae1a6f02 | QAG:eaacb995cc1ef96d27225ab4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "This prompts the hypothesis that cotargeting pan-ERBB with MRTX1133 in PDAC may provide synergistic antitumor activity in some patients and the combination could overcome the acquisition of ERBB conferred resistance to KRAS inhibitors"? Return the original wording with... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a5d723d7357e2d628d4279d4","quotes":["This prompts the hypothesis that cotargeting pan-ERBB with MRTX1133 in PDAC ... | [
"CLM:a5d723d7357e2d628d4279d4",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10502451"
] | [
"SPAN:7eebf4d7f096dacce8b3e395"
] | [] | [] | {"qa_id":"QA:0511e1f7eb5b8b54ae1a6f02","qa_group_id":"QAG:eaacb995cc1ef96d27225ab4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"This prompts the hypothesis that cotargeting pan-ERBB with MRTX113... |
QA:057ad7bfe09526ed72c8db30 | QAG:e48398336e079a5e7aa83e86 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "BK-1361 application in mice decreased tumour burden and metastasis of implanted pancreatic tumour cells and provides improved metrics of clinical symptoms and survival in a Kras G12D -driven mouse model of PDAC"? Return the original wording with paper, Claim, and Evide... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3a8b342380b8b5767d077b32","quotes":["BK-1361 application in mic... | [
"CLM:3a8b342380b8b5767d077b32",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:678d81c62409fb0b2b9c8356",
"CLM:495eedc0a8fd587dcf0ed424",
"CLM:7275e70688cec7ff3c0629b5",
"CLM:7360f34e8ed09772b8f288ba"
] | [
"PMCID:PMC5014123",
"PMCID:PMC5021984",
"PMCID:PMC10689978",
"PMCID:PMC7078253"
] | [
"SPAN:60c489ff7f33ce3d1f36bfb7",
"SPAN:1e471b2cd682ee6248f61399",
"SPAN:cbb9eb431e02fc8a4b6c0f52",
"SPAN:8ffd9db580ae9135ec8810c2"
] | [
"ASC2:652ff22a1329e1027d221204",
"ASC2:ebb90a8cfef6a5f2f2a7b8fd",
"ASC2:4a84d4ea91ad2eb4f1b6f1b1"
] | [
"HYP:DCH:f19874e1da00c414705b33a3"
] | {"qa_id":"QA:057ad7bfe09526ed72c8db30","qa_group_id":"QAG:e48398336e079a5e7aa83e86","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"BK-1361 application in mice decreased tumour burden and metastasis... |
QA:08826a6da7e9a8b5353caf19 | QAG:5b910bbd6c3914cee3b12913 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Importantly, KRB-456 inhibited the in vivo growth of PDXs from patients with pancreatic cancer with disease recurrence after chemotherapy and radiotherapy"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b94626fb567b12f2657428af","quotes":["Importantly, KRB-456 inhibited the in vivo growth of PDXs from patients with... | [
"CLM:b94626fb567b12f2657428af",
"CLM:059d884f031524813698bb57"
] | [
"PMCID:PMC10754035"
] | [
"SPAN:54831820486d65c09db9052f"
] | [] | [] | {"qa_id":"QA:08826a6da7e9a8b5353caf19","qa_group_id":"QAG:5b910bbd6c3914cee3b12913","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Importantly, KRB-456 inhibited the in vivo growth of PDXs from pat... |
QA:088d5903875dce473a6587c2 | QAG:83d0c0b4ba10386c488f79c6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Together, these data suggest that CAF-mediated NRG1 promoted ERBB2/3 activation facilitates KRAS* bypass of PDAC cancer cells"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1ef760c96bde085a3318f070","quotes":["Together, these data suggest that CAF-mediated NRG1-induced ERBB2/3 activati... | [
"CLM:1ef760c96bde085a3318f070",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10621596"
] | [
"SPAN:f3e550731f58f3091e08ce60"
] | [] | [] | {"qa_id":"QA:088d5903875dce473a6587c2","qa_group_id":"QAG:83d0c0b4ba10386c488f79c6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Together, these data suggest that CAF-mediated NRG1 promoted ERBB2... |
QA:097973414ac956c1f46bcc43 | QAG:633b57cfabbf5b90e7cde0e6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "ADAM8 expression was associated with increased invasiveness and reduced patient survival in pancreatic cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with pa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c902549f473033e9dde628bf","quotes":["15. Valkovskaya N, et al. ADAM8 expression is associated with increased inva... | [
"CLM:c902549f473033e9dde628bf",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5014123"
] | [
"SPAN:281cef49b472680ef5324e79"
] | [] | [] | {"qa_id":"QA:097973414ac956c1f46bcc43","qa_group_id":"QAG:633b57cfabbf5b90e7cde0e6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"ADAM8 expression was associated with increased invasiveness and re... |
QA:0989ee51b2c1ef89d2294eee | QAG:73b82c050995b39a8eee0e52 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "These cells have previously been characterized for their ability to eliminate tumor cells during pancreatic cancer development and progression , and patients who have increased CD8-positive populations have improved prognosis"? Return the original wording with paper, C... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3f7abc33a506322c82e2b405","quotes":["These cells have previously been characterized for their ability to eliminat... | [
"CLM:3f7abc33a506322c82e2b405",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5031867"
] | [
"SPAN:9ff560394ba8d72d1e16e794"
] | [] | [] | {"qa_id":"QA:0989ee51b2c1ef89d2294eee","qa_group_id":"QAG:73b82c050995b39a8eee0e52","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"These cells have previously been characterized for their ability t... |
QA:0a0033fb2f0490efe8bce1d6 | QAG:3fb5cad2815b56d9433e74ea | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "We show that ADAM8 expression was associated with increased migration and invasiveness of PDAC cells caused by activation of ERK 1/2 and higher MMP activities"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirem... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d8c75f49552314b1def05602","quotes":["We show that ADAM8 expression is associated with increased migration and inv... | [
"CLM:d8c75f49552314b1def05602",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5014123"
] | [
"SPAN:a27bc70c16f9f53b7ae1c8f1"
] | [] | [] | {"qa_id":"QA:0a0033fb2f0490efe8bce1d6","qa_group_id":"QAG:3fb5cad2815b56d9433e74ea","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"We show that ADAM8 expression was associated with increased migrat... |
QA:0a8d4757264828de179e5528 | QAG:1ad185e4341ef8207f97cf9f | provenance_qa | paper_evidence_availability | provenance_qa | G017 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6078400? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC6078400","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC6078400"
] | [] | [] | [] | {"qa_id":"QA:0a8d4757264828de179e5528","qa_group_id":"QAG:1ad185e4341ef8207f97cf9f","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G017","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6078400... |
QA:0c4ac92c08bc14af2eddfaf8 | QAG:11a2dcaf215999429d0a1427 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Taken together, these lines of evidence strongly support the theory that CXCR2 signaling might play an important role in KRAS promoted tumor cell-autonomous growth by directly contributing to its intracellular signaling during PDAC development and progression"? Return ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e1804e44be7302bcc38e6a9a","quotes":["Taken together, these lines of evidence strongly support the theory that CXC... | [
"CLM:e1804e44be7302bcc38e6a9a",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC4872785"
] | [
"SPAN:c269ad5da8f0b93139708ef6"
] | [] | [] | {"qa_id":"QA:0c4ac92c08bc14af2eddfaf8","qa_group_id":"QAG:11a2dcaf215999429d0a1427","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Taken together, these lines of evidence strongly support the theor... |
QA:0d07121ea5bdba63f0b12698 | QAG:63748e35ae6afe99fe0491d8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "By multiple-genomics data mining we found that the KRAS G12D mutation was significantly associated with the survival of pancreatic patients and identified 4 genes that was associated with KRAS G12D mutation and highly expressed in pancreatic cancer and could regarded a... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1ce41be8f7c7f8444945d61d","quotes":["By multiple-genomics data mining we found that the ... | [
"CLM:1ce41be8f7c7f8444945d61d",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:1e617e1dad162a37feb1db8d"
] | [
"PMCID:PMC9243227",
"PMCID:PMC5031867"
] | [
"SPAN:ecd6eed5ecd05558416da951",
"SPAN:b22e955a759ac76b0821b18c"
] | [
"ASC2:d8a580956f5c88c8188e6a93"
] | [
"HYP:DCH:85d6455c07e997687c45b220"
] | {"qa_id":"QA:0d07121ea5bdba63f0b12698","qa_group_id":"QAG:63748e35ae6afe99fe0491d8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"By multiple-genomics data mining we found that the KRAS G12D mutat... |
QA:0d386d26c3da2ef1838e4f88 | QAG:f7a74652bebc067df73ea96b | provenance_qa | paper_evidence_availability | provenance_qa | G017 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:37321326? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:37321326","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:37321326"
] | [] | [] | [] | {"qa_id":"QA:0d386d26c3da2ef1838e4f88","qa_group_id":"QAG:f7a74652bebc067df73ea96b","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G017","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:37321326? E... |
QA:1005edb005132bd4a788fe18 | QAG:c9ac845a25e2fd1c0c075586 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Our results lead us to three novel findings: i) CXCR2 signaling is upregulated during the primitive stages of KRAS (G12D) promoted PDAC development, ii) upregulation of CXCR2 signaling by KRAS (G12D) enhances autonomous proliferation of tumor cell in PDAC, and iii) KRA... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c172b2322e0a7e860ad7e88b","quotes":["Our results lead us to three novel findings: i) CXCR2 signaling is upregulat... | [
"CLM:c172b2322e0a7e860ad7e88b",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC4872785"
] | [
"SPAN:a669a15bdd64eb57a98e3fbf"
] | [] | [] | {"qa_id":"QA:1005edb005132bd4a788fe18","qa_group_id":"QAG:c9ac845a25e2fd1c0c075586","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Our results lead us to three novel findings: i) CXCR2 signaling is... |
QA:1110a788ce2112bfdb5ffeb7 | QAG:e5e3ec0da2521778b91fc024 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Furthermore, Mang-NPs also inhibited PanIN formation, PDAC development and metastasis in KPC mice, suggesting Mang-NPs can be a useful drug for the treatment and/or prevention of pancreatic cancer which harbor CSCs and progenitor cells"? Return the original wording wit... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:40459a2fcc6c99249af0f4ef","quotes":["Furthermore, Mang-NPs also inhibited PanIN formation, PDAC development and m... | [
"CLM:40459a2fcc6c99249af0f4ef",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5021984"
] | [
"SPAN:5ba07062d366f58998f71967"
] | [] | [] | {"qa_id":"QA:1110a788ce2112bfdb5ffeb7","qa_group_id":"QAG:e5e3ec0da2521778b91fc024","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Furthermore, Mang-NPs also inhibited PanIN formation, PDAC develop... |
QA:12dc20df3f9ef0cc00f6f0be | QAG:bca0dbb0384fdbad9f47ad47 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Importantly, in vivo studies demonstrated that treatment with KRB-456 of mice bearing PDXs from pancreatic cancer patients led to inhibition of the PDX's P-MEK but not P-ERK levels"? Return the original wording with paper, Claim, and Evidence Span references.
Integrat... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:16e43cb05145b77dfb3692eb","quotes":["Importantly, in vivo studies demonstrated that treatment with KRB-456 of mic... | [
"CLM:16e43cb05145b77dfb3692eb",
"CLM:076127dd14e4c335e7256d00"
] | [
"PMCID:PMC10754035"
] | [
"SPAN:91b212b8839790fcac8d00c4"
] | [] | [] | {"qa_id":"QA:12dc20df3f9ef0cc00f6f0be","qa_group_id":"QAG:bca0dbb0384fdbad9f47ad47","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Importantly, in vivo studies demonstrated that treatment with KRB-... |
QA:159d929576e4c4fef12c4385 | QAG:154518cea3602f791f96815a | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Therefore, KRB-456 inhibited tumor growth by 70%, demonstrating that KRB-456 is effective at inhibiting not only subcutaneous PDX tumor growth ( Fig. 6A–D ) but also the orthotopic growth of the tumor derived from patients with pancreatic cancer"? Return the original w... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0ed5038a064e3bc4699e3599","quotes":["Therefore, KRB-456 inhibited tumor growth by 70%, demonstrating that KRB-456... | [
"CLM:0ed5038a064e3bc4699e3599",
"CLM:059d884f031524813698bb57"
] | [
"PMCID:PMC10754035"
] | [
"SPAN:2298fa82716464db482e2ba3"
] | [] | [] | {"qa_id":"QA:159d929576e4c4fef12c4385","qa_group_id":"QAG:154518cea3602f791f96815a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Therefore, KRB-456 inhibited tumor growth by 70%, demonstrating th... |
QA:18511495d89f429bf6622ab7 | QAG:a8767a2ec96262172abb6319 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Notably, at the protein level, low CDK7 expression was associated with enhanced survival specifically in KRAS‐G12V PDAC but not in KRAS‐G12D cases, following multivariable adjustment"? Return the original wording with paper, Claim, and Evidence Span references.
Integr... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:eef7df6a139b370ef7cf0f18","quotes":["Notably, at the protein level, low CDK7 expression was associated with enhan... | [
"CLM:eef7df6a139b370ef7cf0f18",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10689978"
] | [
"SPAN:62b971e4c90ac4a62f2d2a78"
] | [] | [] | {"qa_id":"QA:18511495d89f429bf6622ab7","qa_group_id":"QAG:a8767a2ec96262172abb6319","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Notably, at the protein level, low CDK7 expression was associated ... |
QA:18ba740c1e89621ad5cf13e2 | QAG:17215dd609b046ccc1afa9bb | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "This is the first report of the use of second-generation MEK 1 and 2 inhibitor in combination with a chemotherapy agent that has generated a limited increased survival in a small subset of patients with pancreatic cancer with a known KRAS mutation"? Return the original... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:76f35ddee827870f93880915","quotes":["This is the first report of the use of second-generation MEK 1 and 2 inhibit... | [
"CLM:76f35ddee827870f93880915",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC8655806"
] | [
"SPAN:b4a6ffdec17b8e84d80b61c8"
] | [] | [] | {"qa_id":"QA:18ba740c1e89621ad5cf13e2","qa_group_id":"QAG:17215dd609b046ccc1afa9bb","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"This is the first report of the use of second-generation MEK 1 and... |
QA:192eebdce1253e305876c1a8 | QAG:3ac0e7de323f26e150e77b1b | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Therefore, at least in the case of pancreatic cancer where the tumors appear to be highly dependent on energy from autophagy especially when KRAS or its downstream effectors are inhibited combination of KRB-456 with autophagy inhibitors may also prove to be efficacious... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a38452baf0352642e67c0896","quotes":["Therefore, at least in the case of pancreatic cancer where the tumors appear... | [
"CLM:a38452baf0352642e67c0896",
"CLM:076127dd14e4c335e7256d00"
] | [
"PMCID:PMC10754035"
] | [
"SPAN:59bc2948c4a5296eef53b0e6"
] | [] | [] | {"qa_id":"QA:192eebdce1253e305876c1a8","qa_group_id":"QAG:3ac0e7de323f26e150e77b1b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Therefore, at least in the case of pancreatic cancer where the tum... |
QA:1d0377a8addf221632021511 | QAG:cbe801650aab7906356e4231 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "In our study, Mang-NPs inhibited cell viability of spheroids formed by CSCs isolated from humans and Kras G12D mice, and also inhibit cell proliferation and induce apoptosis in pancreatic cancer cell lines harboring Kras G12D mutations"? Return the original wording wit... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:678d81c62409fb0b2b9c8356","quotes":["In our study, Mang-NPs inhibited cell viability of ... | [
"CLM:678d81c62409fb0b2b9c8356",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:3a8b342380b8b5767d077b32"
] | [
"PMCID:PMC5021984",
"PMCID:PMC5014123"
] | [
"SPAN:1e471b2cd682ee6248f61399",
"SPAN:60c489ff7f33ce3d1f36bfb7"
] | [
"ASC2:652ff22a1329e1027d221204"
] | [
"HYP:DCH:c800690024acd8325f17b8a8"
] | {"qa_id":"QA:1d0377a8addf221632021511","qa_group_id":"QAG:cbe801650aab7906356e4231","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"In our study, Mang-NPs inhibited cell viability of spheroids forme... |
QA:1e2d0789906750afbcae6cc9 | QAG:d2b62bb4e17569c20c3307c4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "K-ras oncogene subtype mutations was associated with survival but not expression of p53, p16INK4A, p21WAF-1, cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma"? Return the original wording with paper, Claim, and Evidence Span references.
Integr... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e0464eb2e9fdd62604a91184","quotes":["12. Kawesha A., Ghaneh P., Andrén-Sandberg Å., Ögraed D., Skar R., Dawiskiba... | [
"CLM:e0464eb2e9fdd62604a91184",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC9562007"
] | [
"SPAN:647d8ee894142880dbd1e4fc"
] | [] | [] | {"qa_id":"QA:1e2d0789906750afbcae6cc9","qa_group_id":"QAG:d2b62bb4e17569c20c3307c4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"K-ras oncogene subtype mutations was associated with survival but ... |
QA:1e3132e7f530598d78b4c53a | QAG:e5f7d288e7dcaa82f686ffa1 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "It has been proved that identical mutations in known driver genes, especially KRAS, were present in every metastatic lesion in all PDAC patients, and the genetic similarity among the cells of metastases was higher than that expected for any two random cells taken from ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:49dbc6047304bd9cc89a3c42","quotes":["It has been proved that identical mutations in known driver genes, especiall... | [
"CLM:49dbc6047304bd9cc89a3c42",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC7078253"
] | [
"SPAN:2d1b1bf839a6b7a09cac0f43"
] | [] | [] | {"qa_id":"QA:1e3132e7f530598d78b4c53a","qa_group_id":"QAG:e5f7d288e7dcaa82f686ffa1","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"It has been proved that identical mutations in known driver genes,... |
QA:1e63285571af350c840372e2 | QAG:6974f01bd919d255a14030d1 | provenance_qa | paper_evidence_availability | provenance_qa | G017 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC4915217? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC4915217","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC4915217"
] | [] | [] | [] | {"qa_id":"QA:1e63285571af350c840372e2","qa_group_id":"QAG:6974f01bd919d255a14030d1","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G017","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC4915217... |
QA:1ee87c217d937d84965ca774 | QAG:2e06165add3cfd756163b211 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Results ETV1 expression was increased in human PanINs and, even more so, in primary and metastatic PDAC"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, C... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3316943333c7f5ea28adb705","quotes":["Results ETV1 expression was significantly increased in human PanINs and, eve... | [
"CLM:3316943333c7f5ea28adb705",
"CLM:076127dd14e4c335e7256d00"
] | [
"PMCID:PMC5002361"
] | [
"SPAN:8ed8066f2584cc3a417caee3"
] | [] | [] | {"qa_id":"QA:1ee87c217d937d84965ca774","qa_group_id":"QAG:2e06165add3cfd756163b211","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Results ETV1 expression was increased in human PanINs and, even mo... |
QA:1f2b9143050077068c0944f5 | QAG:deb5ad22d9e5a4d3eef37592 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "We investigated the function of ETV1 in stromal expansion of PDAC and metastasis, as well as its effects on a novel downstream target Sparc, which encodes a matricellular protein found in PDAC stroma that was associated with invasiveness, metastasis and poor patient ou... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:5f7c8abd12bcb5871cbd4e2e","quotes":["We investigated the function of ETV1 in stromal expansion of PDAC and metast... | [
"CLM:5f7c8abd12bcb5871cbd4e2e",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5002361"
] | [
"SPAN:ff236db1c18d8cfc4397113d"
] | [] | [] | {"qa_id":"QA:1f2b9143050077068c0944f5","qa_group_id":"QAG:deb5ad22d9e5a4d3eef37592","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"We investigated the function of ETV1 in stromal expansion of PDAC ... |
QA:1f7120603f4dd0b8b462922b | QAG:f38d9cdbc086d2d215523df1 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "High expression of SEMA3C in patients was associated with the decreased survival of pancreatic cancer patients based on the TCGA database"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exac... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:51718ce62adae5524bd7ec7d","quotes":["High expression of SEMA3C in patients was significantly associated with the ... | [
"CLM:51718ce62adae5524bd7ec7d",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC9243227"
] | [
"SPAN:a178d37ce038a0ef38d3da57"
] | [] | [] | {"qa_id":"QA:1f7120603f4dd0b8b462922b","qa_group_id":"QAG:f38d9cdbc086d2d215523df1","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"High expression of SEMA3C in patients was associated with the decr... |
QA:21fe8b6b931933e2b9bd3f92 | QAG:590eff06edab126db05769ef | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "We confirmed this observation that the KRAS G12D mutation can lead to increased KRAS expression level in pancreatic cancer patient samples ( Figure 1F )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c9be66a5ef63e3a3c4c923ec","quotes":["We confirmed this observation that the KRAS G12D mutation can lead to increa... | [
"CLM:c9be66a5ef63e3a3c4c923ec",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC9243227"
] | [
"SPAN:7a050cb845f7c42817598b12"
] | [] | [] | {"qa_id":"QA:21fe8b6b931933e2b9bd3f92","qa_group_id":"QAG:590eff06edab126db05769ef","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"We confirmed this observation that the KRAS G12D mutation can lead... |
QA:238cdcad3ad56822a6c64f3b | QAG:15bf9a8540186882932bcafd | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Finally, in patients with PDAC, expression of NUPR1, RELB, and IER3 was correlated with a poor prognosis"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b83370143c66f3aad277f766","quotes":["Finally, in patients with PDAC, expression of NUPR1, RELB, and IER3 was sign... | [
"CLM:b83370143c66f3aad277f766",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC3366404"
] | [
"SPAN:389528ff9da5f6662c738d71"
] | [] | [] | {"qa_id":"QA:238cdcad3ad56822a6c64f3b","qa_group_id":"QAG:15bf9a8540186882932bcafd","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Finally, in patients with PDAC, expression of NUPR1, RELB, and IER... |
QA:23ae83a823cbe0ec6a2c83a2 | QAG:15c012ce735bade220134cea | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Aberrant EGF signalling was associated with ERK1/2 signalling in tumour proliferation and migration of pancreatic cancer cells 45"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact suppor... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:63674cb8e118696c9d0ed773","quotes":["Aberrant EGF signalling is associated with ERK1/2 signalling in tumour proli... | [
"CLM:63674cb8e118696c9d0ed773",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5014123"
] | [
"SPAN:2ee2d76cd703b1f6d059a02b"
] | [] | [] | {"qa_id":"QA:23ae83a823cbe0ec6a2c83a2","qa_group_id":"QAG:15c012ce735bade220134cea","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Aberrant EGF signalling was associated with ERK1/2 signalling in t... |
QA:2606132d1464016e6c5eaa0d | QAG:ccfea0946dde6ae576544ff9 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Although ADAM8 was associated with increased tumour cell migration, invasiveness and metastasis via a combination of catalytic, adhesion and cell signalling functions 15 , 20 , no mechanistic data on ADAM8 in tumour progression, and specifically in PDAC are available"?... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b95f1a6086fb00c3fd33cc8d","quotes":["Although ADAM8 has been associated with increased tumour cell migration, inv... | [
"CLM:b95f1a6086fb00c3fd33cc8d",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5014123"
] | [
"SPAN:2f2a61fe8a0091564cc5941a"
] | [] | [] | {"qa_id":"QA:2606132d1464016e6c5eaa0d","qa_group_id":"QAG:ccfea0946dde6ae576544ff9","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Although ADAM8 was associated with increased tumour cell migration... |
QA:28a2a43bd4a62eed068a1a3d | QAG:93206cfcfc45d0fb03e6e2dc | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Inhibition of SEMA3C with the SEMA3C special inhibitor 3,5,4’-Tribromosalicylanilide led to cell cycle arrest and apoptosis increase in pancreatic cancer cell lines ( Figures 3D, E )"? Return the original wording with paper, Claim, and Evidence Span references.
Integr... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:74136d490a188f40d37b5606","quotes":["Inhibition of SEMA3C with the SEMA3C special inhibitor 3,5,4’-Tribromosalicy... | [
"CLM:74136d490a188f40d37b5606",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC9243227"
] | [
"SPAN:591d526d68d0ceba55b357e1"
] | [] | [] | {"qa_id":"QA:28a2a43bd4a62eed068a1a3d","qa_group_id":"QAG:93206cfcfc45d0fb03e6e2dc","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Inhibition of SEMA3C with the SEMA3C special inhibitor 3,5,4’-Trib... |
QA:291cc1f0da1379e8c8e25fba | QAG:4cbc2048063631757f174ac3 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "In the first-in-human trial of trametinib monotherapy, 2 of the 26 PDAC patients who had received an unlimited number of previous treatments achieved PR"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4a1320732d6e3cfb77069c42","quotes":["In the first-in-human trial of trametinib monotherapy, 2 of the 26 PDAC pati... | [
"CLM:4a1320732d6e3cfb77069c42",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10563303"
] | [
"SPAN:3c9ff13ca3a8ec3a9bfa2d2a"
] | [] | [] | {"qa_id":"QA:291cc1f0da1379e8c8e25fba","qa_group_id":"QAG:4cbc2048063631757f174ac3","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"In the first-in-human trial of trametinib monotherapy, 2 of the 26... |
QA:2a7d44eb1da4612685221402 | QAG:7be5af2c061be841c1ea5d5c | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Figure 8 The role of CXCR2 signaling in KRAS (G12D) -induced development of pancreatic cancer Based on data in the current study, and previously published reports we can summarize the role of CXCR2 signaling in KRAS promoted initiation and progression of pancreatic can... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7ed72cc6ce990c29a7fe9dd6","quotes":["Figure 8 The role of CXCR2 signaling in KRAS (G12D) -induced development of ... | [
"CLM:7ed72cc6ce990c29a7fe9dd6",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC4872785"
] | [
"SPAN:83dbab950f169fde89a9076e"
] | [] | [] | {"qa_id":"QA:2a7d44eb1da4612685221402","qa_group_id":"QAG:7be5af2c061be841c1ea5d5c","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Figure 8 The role of CXCR2 signaling in KRAS (G12D) -induced devel... |
QA:2a9f1c96022d6158cfd1d28c | QAG:ec0f61261390260315686304 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "In CAPAN2 PDAC cells with KRAS‐G12V mutation, the level of PIK3CA in the DNA bound by H3K27ac antibody was higher than in that bound by H3K9me3 antibody or IgG antibody, suggesting that histone H3K27 might regulate PIK3CA expression through acetylation (Figure 5A )"? R... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:611e598b61a8ce1289610c80","quotes":["C and E shared the same set of controls, and E and F shared the same set of ... | [
"CLM:611e598b61a8ce1289610c80",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10689978"
] | [
"SPAN:ace4ec885941c5572eeb92fb"
] | [] | [] | {"qa_id":"QA:2a9f1c96022d6158cfd1d28c","qa_group_id":"QAG:ec0f61261390260315686304","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"In CAPAN2 PDAC cells with KRAS‐G12V mutation, the level of PIK3CA ... |
QA:2b37fc7fbafd940f8bcd04a7 | QAG:aea6ff67c3c67152abf655a2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Here, we report that sequential administration of CDK4/6 inhibitors after taxanes cooperated to prevent cellular proliferation in pancreatic ductal adenocarcinoma (PDAC) cells, patient-derived xenografts, and genetically engineered mice with Kras G12V and Cdkn2a-null m... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c0713d25a8a5df224b4a71bf","quotes":["Here, we report that sequential administration of CDK4/6 inhibitors after ta... | [
"CLM:c0713d25a8a5df224b4a71bf",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMID:32109375"
] | [
"SPAN:3be4d81eea7e082641ad913d"
] | [] | [] | {"qa_id":"QA:2b37fc7fbafd940f8bcd04a7","qa_group_id":"QAG:aea6ff67c3c67152abf655a2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Here, we report that sequential administration of CDK4/6 inhibitor... |
QA:2d906923689478fed822594d | QAG:b429bf68c615ef14429efce1 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "SMAD4 gene mutations was associated with poor prognosis in pancreatic cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span ref... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:409b26c8648f6aebc2222978","quotes":["15. Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Pa... | [
"CLM:409b26c8648f6aebc2222978",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC8855595"
] | [
"SPAN:cd0f3a49205da60f6ae89e76"
] | [] | [] | {"qa_id":"QA:2d906923689478fed822594d","qa_group_id":"QAG:b429bf68c615ef14429efce1","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"SMAD4 gene mutations was associated with poor prognosis in pancrea... |
QA:2fda05c38e7c3af82a85b7b8 | QAG:e28aee9b520062d51eeef1db | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Their data revealed that treatment of PDAC cell lines HPAC and Colo357, with CXCR2 agonists CXCL1, 5 and 8 increased their in vitro cell proliferation"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: re... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:daaaec99656e20a68c8adaa1","quotes":["Their data revealed that treatment of PDAC cell lines HPAC and Colo357, with... | [
"CLM:daaaec99656e20a68c8adaa1",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC4872785"
] | [
"SPAN:7db400d2a35bcf6ec4e94e25"
] | [] | [] | {"qa_id":"QA:2fda05c38e7c3af82a85b7b8","qa_group_id":"QAG:e28aee9b520062d51eeef1db","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Their data revealed that treatment of PDAC cell lines HPAC and Col... |
QA:31c3f7a26d5fc61828d6fbb9 | QAG:6346151608289af899f08a38 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "A total of 151 Chinese head PDAC patients were enrolled in this study"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span references... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:25d85042b4731b761d6256ca","quotes":["A total of 151 Chinese head PDAC patients were enrolled in this study."],"ci... | [
"CLM:25d85042b4731b761d6256ca",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC8855595"
] | [
"SPAN:372f0c61d32b52e0bf2604b0"
] | [] | [] | {"qa_id":"QA:31c3f7a26d5fc61828d6fbb9","qa_group_id":"QAG:6346151608289af899f08a38","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"A total of 151 Chinese head PDAC patients were enrolled in this st... |
QA:32a694c1baa165e2a242db01 | QAG:5f705f09ba55e94bcde3b6a7 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Targeting of KRAS in pancreatic cancer except for the G12C mutation may be achieved by using SOS1 inhibitors that as single drug are expected to possess limited anticancer activity"? Return the original wording with paper, Claim, and Evidence Span references.
Integrat... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a0fad6ceba9061c1b59b6aaa","quotes":["Targeting of KRAS in pancreatic cancer except for t... | [
"CLM:a0fad6ceba9061c1b59b6aaa",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:444f90f59f200a89a8ab387f"
] | [
"PMCID:PMC9437170",
"PMCID:PMC10502451"
] | [
"SPAN:c7e719df157687b1d5c64112",
"SPAN:ff3cfcb01ca1e36ba70f36ff"
] | [
"ASC2:4f9021b99acad3d64ddd91d2"
] | [
"HYP:DCH:65ad1100d608bb01b156fa7b"
] | {"qa_id":"QA:32a694c1baa165e2a242db01","qa_group_id":"QAG:5f705f09ba55e94bcde3b6a7","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Targeting of KRAS in pancreatic cancer except for the G12C mutatio... |
QA:35c29dcec7d20cd9024b068c | QAG:35d0eda99cd3210ea4bc3c75 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "p27 Kip1 protein levels were increased in stably Efemp1 transfected clones compared to the control clone (figure 4A )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:af40830173c8c464e0344f98","quotes":["Since we have demonstrated that inhibition of the PI3K pathway in human PDAC... | [
"CLM:af40830173c8c464e0344f98",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC3712573"
] | [
"SPAN:e6b7b6adf3a67f5b37a14aed"
] | [] | [] | {"qa_id":"QA:35c29dcec7d20cd9024b068c","qa_group_id":"QAG:35d0eda99cd3210ea4bc3c75","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"p27 Kip1 protein levels were increased in stably Efemp1 transfecte... |
QA:387ee8f9e1f9e3a2d6075a7a | QAG:22cdf370048e3913fb16f0ce | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Our results lead us to three novel findings: i) CXCR2 signaling is upregulated during the primitive stages of KRAS (G12D) -induced PDAC development, ii) upregulation of CXCR2 signaling by KRAS (G12D) enhances autonomous proliferation of tumor cell in PDAC, and iii) KRA... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7750704a63e464571fe5b22e","quotes":["Our results lead us to three novel findings: i) CXCR2 signaling is upregulat... | [
"CLM:7750704a63e464571fe5b22e",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC4872785"
] | [
"SPAN:a669a15bdd64eb57a98e3fbf"
] | [] | [] | {"qa_id":"QA:387ee8f9e1f9e3a2d6075a7a","qa_group_id":"QAG:22cdf370048e3913fb16f0ce","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Our results lead us to three novel findings: i) CXCR2 signaling is... |
QA:3ab9c45a97c1a276927caeff | QAG:2fde572b76241ca87a088775 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "This effect was correlated with the repressive activity of CDK4/6 inhibitors on homologous recombination proteins required for the recovery from chromosomal damage"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance req... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a287e8c7ffc2efa86c193a5f","quotes":["This effect correlates with the repressive activity... | [
"CLM:a287e8c7ffc2efa86c193a5f",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:1ffc8ab102fcd155de208356",
"CLM:495eedc0a8fd587dcf0ed424",
"CLM:7275e70688cec7ff3c0629b5"
] | [
"PMID:32109375",
"PMCID:PMC10689978",
"PMCID:PMC5014123"
] | [
"SPAN:3be4d81eea7e082641ad913d",
"SPAN:a50e24a940e351e52d23f00d",
"SPAN:3d63ec2c1837733c29bec348",
"SPAN:60c489ff7f33ce3d1f36bfb7",
"SPAN:cbb9eb431e02fc8a4b6c0f52"
] | [
"ASC2:09d43da4eaee7444900c647d",
"ASC2:ebb90a8cfef6a5f2f2a7b8fd"
] | [
"HYP:DCH:e1b9e7412061df61804bfe0e"
] | {"qa_id":"QA:3ab9c45a97c1a276927caeff","qa_group_id":"QAG:2fde572b76241ca87a088775","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"This effect was correlated with the repressive activity of CDK4/6 ... |
QA:3d90f8d06f188ead9cdbb892 | QAG:50e7be5496ccfd8810885c32 | provenance_qa | paper_evidence_availability | provenance_qa | G017 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC4310684? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC4310684","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC4310684"
] | [] | [] | [] | {"qa_id":"QA:3d90f8d06f188ead9cdbb892","qa_group_id":"QAG:50e7be5496ccfd8810885c32","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G017","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC4310684... |
QA:401e605d8a0348fd490e5b60 | QAG:0e7da585a8324678e9a775d7 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "CDK4/6 inhibitors also prevented recovery from multiple DNA-damaging agents, suggesting broad applicability for their sequential administration after available chemotherapeutic agents"? Return the original wording with paper, Claim, and Evidence Span references.
Integ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:db19ecce42b74a7e70a68114","quotes":["CDK4/6 inhibitors also prevent recovery from multiple DNA-damaging agents, s... | [
"CLM:db19ecce42b74a7e70a68114",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMID:32109375"
] | [
"SPAN:28f8c02733c33cbec849b530"
] | [] | [] | {"qa_id":"QA:401e605d8a0348fd490e5b60","qa_group_id":"QAG:0e7da585a8324678e9a775d7","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"CDK4/6 inhibitors also prevented recovery from multiple DNA-damagi... |
QA:462eda2dd4fa7978f07db6ec | QAG:85986f9ad6e8c3a17343a686 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "1 Life expectancy of pancreatic cancer patients has improved slightly, with a 5-year overall survival (OS) of ∼9%"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage wit... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6ea58ec6f1f3a32a1b4d1e46","quotes":["1 Life expectancy of pancreatic cancer patients has improved slightly, with ... | [
"CLM:6ea58ec6f1f3a32a1b4d1e46",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC8655806"
] | [
"SPAN:8638bc2dd3e30338cb638a46"
] | [] | [] | {"qa_id":"QA:462eda2dd4fa7978f07db6ec","qa_group_id":"QAG:85986f9ad6e8c3a17343a686","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"1 Life expectancy of pancreatic cancer patients has improved sligh... |
QA:4803f683be62a5de8d0dfd22 | QAG:ce2b656948e9e2a70d6d7105 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Human pancreatic cancer cell lines Panc0203 and Panc1 received the indicated concentrations of KRB-456 and processed for viability assays (72 hours), Panc0203 (open circles) and Panc1 (closed circles; A ), GST-RBD pulldown (“G” designates GST-RBD only with no lysate ad... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6eea8d84332c3bfd458397da","quotes":["Human pancreatic cancer cell lines Panc0203 and Panc1 were treated with the ... | [
"CLM:6eea8d84332c3bfd458397da",
"CLM:0ec8c966f611d4a287f71b62"
] | [
"PMCID:PMC10754035"
] | [
"SPAN:1884afd42bdd10d52a442998"
] | [] | [] | {"qa_id":"QA:4803f683be62a5de8d0dfd22","qa_group_id":"QAG:ce2b656948e9e2a70d6d7105","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Human pancreatic cancer cell lines Panc0203 and Panc1 received the... |
QA:482f5d9ff794be15c1686966 | QAG:98792374d6891072ed88330f | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "In addition, it was revealed that human primary PDAC tumors with increased Snail expression was associated with increased mast cell infiltration, and that Snail expression in these clinical specimens positively correlated with the expression of stem cell factor (SCF/KI... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9d771420260b66ec221ab417","quotes":["In addition, it was revealed that human primary PDAC tumors with increased S... | [
"CLM:9d771420260b66ec221ab417",
"CLM:076127dd14e4c335e7256d00"
] | [
"PMCID:PMC4201957"
] | [
"SPAN:3a7531b8557ffd2016e99362"
] | [] | [] | {"qa_id":"QA:482f5d9ff794be15c1686966","qa_group_id":"QAG:98792374d6891072ed88330f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"In addition, it was revealed that human primary PDAC tumors with i... |
QA:495e1fbf7c1b8c6d205c8959 | QAG:7347b33933854376f7bdb9b4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Our data demonstrates that CXCR2 signaling mediates KRAS promoted PC growth and suggests that targeting CXCR2 signaling might be a feasible approach to inhibit KRAS (G12D) -induced PDAC tumor cell growth"? Return the original wording with paper, Claim, and Evidence Spa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:58c3aabd45213e6fefd0b7dd","quotes":["Our data demonstrates that CXCR2 signaling mediates... | [
"CLM:58c3aabd45213e6fefd0b7dd",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:7275e70688cec7ff3c0629b5"
] | [
"PMCID:PMC4872785",
"PMCID:PMC5014123"
] | [
"SPAN:177d275f9b3267715aa115d0",
"SPAN:60c489ff7f33ce3d1f36bfb7"
] | [
"ASC2:ad4284cc250ff06e0624099b"
] | [
"HYP:DCH:8a3c9970364c453596a2ba4f"
] | {"qa_id":"QA:495e1fbf7c1b8c6d205c8959","qa_group_id":"QAG:7347b33933854376f7bdb9b4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Our data demonstrates that CXCR2 signaling mediates KRAS promoted ... |
QA:4bf4c5c1ab0f95250ab02578 | QAG:d690780b16978b50272e887b | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Conclusion: Our pancreatic cancer patients were heavily pretreated (all had received FOLFIRINOX and gemcitabine/nab-paclitaxel) before the entry into our trial"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance require... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e5f04344faa57ec5e328c09f","quotes":["Conclusion: Our pancreatic cancer patients were heavily pretreated (all had ... | [
"CLM:e5f04344faa57ec5e328c09f",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC8655806"
] | [
"SPAN:2d8065f812ae6b2e6d1673fb"
] | [] | [] | {"qa_id":"QA:4bf4c5c1ab0f95250ab02578","qa_group_id":"QAG:d690780b16978b50272e887b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Conclusion: Our pancreatic cancer patients were heavily pretreated... |
QA:4c952f3e0377cec3e61db4f6 | QAG:c1e6a3318342f0a067dddd95 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Supplementary Figure S10A shows representative live-cell images of cells derived from patient 107 where KRB-456 inhibited the viability of these pancreatic cancer cells in a dose-dependent manner"? Return the original wording with paper, Claim, and Evidence Span refere... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b4c5ea61cbad5e077bc47cb1","quotes":["Supplementary Figure S10A shows representative live-cell images of cells der... | [
"CLM:b4c5ea61cbad5e077bc47cb1",
"CLM:076127dd14e4c335e7256d00"
] | [
"PMCID:PMC10754035"
] | [
"SPAN:f68a755ecb899991b2deb57f"
] | [] | [] | {"qa_id":"QA:4c952f3e0377cec3e61db4f6","qa_group_id":"QAG:c1e6a3318342f0a067dddd95","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Supplementary Figure S10A shows representative live-cell images of... |
QA:4e90125a258f33aa5cab47ef | QAG:e0e7df16cbd49a42edb106c6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Our data demonstrates that CXCR2 signaling mediates KRAS-induced PC growth and suggests that targeting CXCR2 signaling might be a feasible approach to inhibit KRAS (G12D) promoted PDAC tumor cell growth"? Return the original wording with paper, Claim, and Evidence Span... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6c525db7f7a18b4774c2128c","quotes":["Our data demonstrates that CXCR2 signaling mediates KRAS-induced PC growth a... | [
"CLM:6c525db7f7a18b4774c2128c",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC4872785"
] | [
"SPAN:177d275f9b3267715aa115d0"
] | [] | [] | {"qa_id":"QA:4e90125a258f33aa5cab47ef","qa_group_id":"QAG:e0e7df16cbd49a42edb106c6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Our data demonstrates that CXCR2 signaling mediates KRAS-induced P... |
QA:52866d54b1623242de5adcc1 | QAG:cf2a7d85537c33a577e45460 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Experiments with mouse xenograft models of pancreatic cancer showed that TH-Z835 decreased tumor volume and synergized with an anti-PD-1 antibody"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d1575fc151ae32e02ebefc33","quotes":["Experiments with mouse xenograft models of pancreatic cancer showed that TH-... | [
"CLM:d1575fc151ae32e02ebefc33",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC8786924"
] | [
"SPAN:8c3b16bd088cadef349458f7"
] | [] | [] | {"qa_id":"QA:52866d54b1623242de5adcc1","qa_group_id":"QAG:cf2a7d85537c33a577e45460","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Experiments with mouse xenograft models of pancreatic cancer showe... |
QA:54c2f037125d7ab3932a7da8 | QAG:09516eb08852441f22b214ad | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "05 treated with human anti-ERBB2 antibody (pertuzumab) showed decreased activation of ERBB3, AKT, and ERK upon addition of CAF-pro or rmNRG1 ( Fig. 2 H; Supplemental Fig. S2G )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated p... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0a01e893027b3e621e4f91bf","quotes":["Consistent with these murine findings, human PDAC c... | [
"CLM:0a01e893027b3e621e4f91bf",
"CLM:059d884f031524813698bb57",
"CLM:b678433eae4217cf427a058d"
] | [
"PMCID:PMC10621596",
"PMCID:PMC10502451"
] | [
"SPAN:c12b2be3f0cefe5d09c80a1c",
"SPAN:c550813ad571a7032d61e703"
] | [
"ASC2:2081421064866f4cf693412a"
] | [
"HYP:DCH:2c2ce6715968cc21dac7c5b5"
] | {"qa_id":"QA:54c2f037125d7ab3932a7da8","qa_group_id":"QAG:09516eb08852441f22b214ad","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"05 treated with human anti-ERBB2 antibody (pertuzumab) showed decr... |
QA:5712f9a638a9a65641673cdd | QAG:fcff25648cc5e374f2f95863 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "From August 2014 to August 2015, a total of 130 consecutive patients diagnosed with resectable PDAC who underwent curative pancreatectomy were enrolled from the Changhai prospective database (Fig. 1 )"? Return the original wording with paper, Claim, and Evidence Span r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d2bfaf0606d45c37cc4fdbf8","quotes":["From August 2014 to August 2015, a total of 130 consecutive patients diagnos... | [
"CLM:d2bfaf0606d45c37cc4fdbf8",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC7078253"
] | [
"SPAN:2fc6e0e796ba098ca61beac6"
] | [] | [] | {"qa_id":"QA:5712f9a638a9a65641673cdd","qa_group_id":"QAG:fcff25648cc5e374f2f95863","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"From August 2014 to August 2015, a total of 130 consecutive patien... |
QA:58ae64388089aecc00a6c611 | QAG:8f67a97b70d7077de9b361a8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "FIGURE 3 THZ1 suppressed the global transcription in pancreatic ductal adenocarcinoma (PDAC), which was associated with the RNA polymerase II (RNAPOLII) activity, and THZ1 selectively inhibited the expression and phosphorylation of RNAPOLII and super‐enhancer (SE) acti... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a37803d4f8aea5472a3ad46b","quotes":["FIGURE 3 THZ1 suppressed the global transcription in pancreatic ductal adeno... | [
"CLM:a37803d4f8aea5472a3ad46b",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10689978"
] | [
"SPAN:b8396a94cf7f5e7c56ae004e"
] | [] | [] | {"qa_id":"QA:58ae64388089aecc00a6c611","qa_group_id":"QAG:8f67a97b70d7077de9b361a8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"FIGURE 3 THZ1 suppressed the global transcription in pancreatic du... |
QA:5a734d2ab8dcd4842992d9e4 | QAG:03be7b4aae079bba71e0b321 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "7A , KRB-456 mouse treatment decreased the levels of P-MEK, P-AKT, and P-S6 but not P-ERK (see Discussion) in the pancreatic cancer PDX G160 in vivo"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: retu... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f48371553cb4919033b14112","quotes":["As shown in Fig. 7A , KRB-456 mouse treatment decreased the levels of P-MEK,... | [
"CLM:f48371553cb4919033b14112",
"CLM:076127dd14e4c335e7256d00"
] | [
"PMCID:PMC10754035"
] | [
"SPAN:f7f1cbc4eb19d839ad38a365"
] | [] | [] | {"qa_id":"QA:5a734d2ab8dcd4842992d9e4","qa_group_id":"QAG:03be7b4aae079bba71e0b321","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"7A , KRB-456 mouse treatment decreased the levels of P-MEK, P-AKT,... |
QA:5b1f97587c3448884e74a038 | QAG:22f71e78977dc754f42e923d | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Furthermore, in a previous study, we found that inhibition of KRAS downstream signaling using MEK1/2 and AKT inhibitors in PDAC patient-derived organoids (PDO) led to the hyperactivation of EGFR, HER2, and HER3 ( 10 )"? Return the original wording with paper, Claim, an... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b678433eae4217cf427a058d","quotes":["Furthermore, in a previous study, we found that inhibition of KRAS downstrea... | [
"CLM:b678433eae4217cf427a058d",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10502451"
] | [
"SPAN:c550813ad571a7032d61e703"
] | [] | [] | {"qa_id":"QA:5b1f97587c3448884e74a038","qa_group_id":"QAG:22f71e78977dc754f42e923d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Furthermore, in a previous study, we found that inhibition of KRAS... |
QA:5cb71dbd1b1d4f102850e68d | QAG:e62f5aa54236906f53a9d129 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "In mini‐CDX models, 10 mg/kg THZ1 distinctly suppressed CAPAN2 ( KRAS‐G12V ) cancer cells, evident through both decreased RFU and T/C (%) values compared with the vehicle control group on day 7 ( p = .022; Figure 2E )"? Return the original wording with paper, Claim, an... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c519d717961c8b32ce624c0f","quotes":["(E, F) Mini‐CDX models revealed that THZ1 selectively suppressed PDAC based ... | [
"CLM:c519d717961c8b32ce624c0f",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10689978"
] | [
"SPAN:3d63ec2c1837733c29bec348"
] | [] | [] | {"qa_id":"QA:5cb71dbd1b1d4f102850e68d","qa_group_id":"QAG:e62f5aa54236906f53a9d129","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"In mini‐CDX models, 10 mg/kg THZ1 distinctly suppressed CAPAN2 ( K... |
QA:61000744bbc8e19a64d9500b | QAG:289d680d9f5d4db293b922b1 | provenance_qa | paper_evidence_availability | provenance_qa | G017 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC3540949? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC3540949","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC3540949"
] | [] | [] | [] | {"qa_id":"QA:61000744bbc8e19a64d9500b","qa_group_id":"QAG:289d680d9f5d4db293b922b1","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G017","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC3540949... |
QA:6113a3ebc05574140e4c2509 | QAG:63ef7ba442cf5ec1ce624509 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Treatment with the H-REV107 peptide effectively inhibited pancreatic cancer and colon cancer cell lines in cell proliferation assay by inducing apoptosis"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements:... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d6b550412d7a606c5aab6de8","quotes":["Treatment with the H-REV107 peptide effectively inhibited pancreatic cancer ... | [
"CLM:d6b550412d7a606c5aab6de8",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC7352977"
] | [
"SPAN:b947ac03973e5a60f0f8c8a4"
] | [] | [] | {"qa_id":"QA:6113a3ebc05574140e4c2509","qa_group_id":"QAG:63ef7ba442cf5ec1ce624509","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Treatment with the H-REV107 peptide effectively inhibited pancreat... |
QA:6438dfb06b5d779b55146799 | QAG:7580cca6fde6d5e750a6c7c0 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "(E, F) Mini‐CDX models revealed that THZ1 selectively inhibited PDAC based on the KRAS mutation subtype, as reflected by relative fluorescence units (RFUs) and relative proliferation rates (T/C (%)) of tumour cells (E, CAPAN2; F, SW1990) treated with vehicle control an... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:bb1a3037d452b0e9db470159","quotes":["(E, F) Mini‐CDX models revealed that THZ1 selectively suppressed PDAC based ... | [
"CLM:bb1a3037d452b0e9db470159",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10689978"
] | [
"SPAN:3d63ec2c1837733c29bec348"
] | [] | [] | {"qa_id":"QA:6438dfb06b5d779b55146799","qa_group_id":"QAG:7580cca6fde6d5e750a6c7c0","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"(E, F) Mini‐CDX models revealed that THZ1 selectively inhibited PD... |
QA:64d14e18c108fb50a94b70c3 | QAG:0625c6552e24add26d64497d | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "In this retrospective cohort study examining the correlation between the presence of a KRAS G12D mutation subtype and prognosis in PDAC across all stages of disease, we found that the presence of a KRAS G12D mutation was associated with reduced survival in those with r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b93cf21ca43e3c42d6daa92c","quotes":["In this retrospective cohort study examining the co... | [
"CLM:b93cf21ca43e3c42d6daa92c",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:1ffc8ab102fcd155de208356",
"CLM:a287e8c7ffc2efa86c193a5f",
"CLM:8bebff78bf8e21b4c401bc61"
] | [
"PMCID:PMC9562007",
"PMCID:PMC10689978",
"PMID:32109375"
] | [
"SPAN:19e4549f0a67f671e279c4d9",
"SPAN:3be4d81eea7e082641ad913d",
"SPAN:3d63ec2c1837733c29bec348",
"SPAN:a50e24a940e351e52d23f00d",
"SPAN:cbb9eb431e02fc8a4b6c0f52"
] | [
"ASC2:09d43da4eaee7444900c647d",
"ASC2:6541f09501ed92359672d61c"
] | [
"HYP:DCH:1a4ba8283077ae4ed96c6d5e"
] | {"qa_id":"QA:64d14e18c108fb50a94b70c3","qa_group_id":"QAG:0625c6552e24add26d64497d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"In this retrospective cohort study examining the correlation betwe... |
QA:65d4ad49b4bd1dd721d07506 | QAG:e5a3f178ae14d5aa7e556f49 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "FIGURE 4 The expression of CDK7 was associated with the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma (PDAC)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting p... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:225427ba1691c4daf5ac3617","quotes":["FIGURE 4 The expression of CDK7 was positively associated with the PI3K/AKT/... | [
"CLM:225427ba1691c4daf5ac3617",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10689978"
] | [
"SPAN:6e81ba0f47c30c6cb67ce2ab"
] | [] | [] | {"qa_id":"QA:65d4ad49b4bd1dd721d07506","qa_group_id":"QAG:e5a3f178ae14d5aa7e556f49","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"FIGURE 4 The expression of CDK7 was associated with the PI3K/AKT/m... |
QA:6809852499a3341c1ae82f3d | QAG:c9d8aec3e61c25757416df2c | provenance_qa | paper_evidence_availability | provenance_qa | G017 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC10577700? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiabl... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC10577700","verdict":"no_released_traceable_claim","reason":"No... | [] | [
"PMCID:PMC10577700"
] | [] | [] | [] | {"qa_id":"QA:6809852499a3341c1ae82f3d","qa_group_id":"QAG:c9d8aec3e61c25757416df2c","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G017","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC1057770... |
QA:68cd726e6627404f0fd7ee38 | QAG:4655d5b9fa51f8401b809c7f | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "It is remarkable how significantly ADAM8 led to tumour cell invasion and metastasis in the PDAC models"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Cl... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:56e09d316c5a59ac101455ee","quotes":["It is remarkable how significantly ADAM8 contributed to tumour cell invasion... | [
"CLM:56e09d316c5a59ac101455ee",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5014123"
] | [
"SPAN:e68e9d7a9ef8f44afd5336b5"
] | [] | [] | {"qa_id":"QA:68cd726e6627404f0fd7ee38","qa_group_id":"QAG:4655d5b9fa51f8401b809c7f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"It is remarkable how significantly ADAM8 led to tumour cell invasi... |
QA:6ad0a0f7d39ca88d3e4d7516 | QAG:89e1eb5dde1ddd03ea36a596 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "This retrospective cohort study aims to evaluate whether detection of the KRAS G12D mutation subtype in PDAC patients is a determinant of prognosis across all stages of disease"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated p... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a131f7cb294db296b0c6688f","quotes":["This retrospective cohort study aims to investigate... | [
"CLM:a131f7cb294db296b0c6688f",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:58c3aabd45213e6fefd0b7dd"
] | [
"PMCID:PMC9562007",
"PMCID:PMC4872785"
] | [
"SPAN:a550c4dabbbaf2757d1f3965",
"SPAN:177d275f9b3267715aa115d0"
] | [
"ASC2:c76af821a1eef45e1e54d52c"
] | [] | {"qa_id":"QA:6ad0a0f7d39ca88d3e4d7516","qa_group_id":"QAG:89e1eb5dde1ddd03ea36a596","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"This retrospective cohort study aims to evaluate whether detection... |
QA:6cb36fece21b067c9d2cc8a2 | QAG:1253bc7e0d4144b5fbf35cb2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Patients with PDAC who received trametinib in combination with HCQ or CDK4/6 inhibitors as third- or later-line therapy at Peking Union Medical College Hospital (PUMCH) between June 2020 and December 2022 were reviewed using the Electronic Medical Record Analytical Dat... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d9ac8241f5236d1596fda3c6","quotes":["Patients with PDAC who received trametinib in combination with HCQ or CDK4/6... | [
"CLM:d9ac8241f5236d1596fda3c6",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10563303"
] | [
"SPAN:7c4ef0f12bd9d4fb2ac68924"
] | [] | [] | {"qa_id":"QA:6cb36fece21b067c9d2cc8a2","qa_group_id":"QAG:1253bc7e0d4144b5fbf35cb2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Patients with PDAC who received trametinib in combination with HCQ... |
QA:6dd6322311623695d09c9448 | QAG:56a8b4ad5ff205588a1c161f | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "reported that 10 patients with PDAC received MEK inhibitors (trametinib or cobimetinib) combined with HCQ"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper,... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ab6c9b65722d4a3039184c6f","quotes":["Interestingly, Mehdi et al. [ 23 ] reported that 10 patients with PDAC recei... | [
"CLM:ab6c9b65722d4a3039184c6f",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10563303"
] | [
"SPAN:ee4134ab72c609e4c39fa840"
] | [] | [] | {"qa_id":"QA:6dd6322311623695d09c9448","qa_group_id":"QAG:56a8b4ad5ff205588a1c161f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"reported that 10 patients with PDAC received MEK inhibitors (trame... |
QA:6dde4a246c3a79873a1a8b48 | QAG:fc1d2661eac4ef08f1c9e8d8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "FIGURE 3 THZ1 inhibited the global transcription in pancreatic ductal adenocarcinoma (PDAC), which was associated with the RNA polymerase II (RNAPOLII) activity, and THZ1 selectively inhibited the expression and phosphorylation of RNAPOLII and super‐enhancer (SE) activ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e1372e28804ee6205515b840","quotes":["FIGURE 3 THZ1 suppressed the global transcription in pancreatic ductal adeno... | [
"CLM:e1372e28804ee6205515b840",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC10689978"
] | [
"SPAN:b8396a94cf7f5e7c56ae004e"
] | [] | [] | {"qa_id":"QA:6dde4a246c3a79873a1a8b48","qa_group_id":"QAG:fc1d2661eac4ef08f1c9e8d8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"FIGURE 3 THZ1 inhibited the global transcription in pancreatic duc... |
QA:70d56a7d702209c0adf7bcf1 | QAG:f922d9dcb8092713555a4cff | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Results : KRAS G12D mutation subtype was not associated with poorer survival compared across the whole population of PDAC patients ( p = 0.107; HR 1.293 95% CI (0.946–1.767))"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated pro... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3b5216e88f7fc69c798ae681","quotes":["Results : KRAS G12D mutation subtype was not signif... | [
"CLM:3b5216e88f7fc69c798ae681",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:1ba56b7c008ca1b05a9486cf"
] | [
"PMCID:PMC9562007",
"PMCID:PMC9243227"
] | [
"SPAN:7f12f0a4980f301bb2819933",
"SPAN:ecd6eed5ecd05558416da951"
] | [
"ASC2:b33262e9fb63e818f232e3af"
] | [
"HYP:DCH:a01a31c814db3d1606ae2755"
] | {"qa_id":"QA:70d56a7d702209c0adf7bcf1","qa_group_id":"QAG:f922d9dcb8092713555a4cff","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Results : KRAS G12D mutation subtype was not associated with poore... |
QA:723b0496ee2f2848910a6dea | QAG:ea7fd8c93c95684adc7efc50 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "Pdx-1-Cre (KPC) mice showed that ETS2 expression initially increased in fibroblasts during ADM and remained elevated through progression to PDAC"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return t... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1f8f93e20c9d81b5d43e4d2d","quotes":["LSL-Kras G12D/+ ; LSL-Trp53 R172H/+ ; Pdx-1-Cre (KP... | [
"CLM:1f8f93e20c9d81b5d43e4d2d",
"CLM:001c7a79ecd0dfbb4975d549",
"CLM:a131f7cb294db296b0c6688f"
] | [
"PMCID:PMC5031867",
"PMCID:PMC9562007"
] | [
"SPAN:b22e955a759ac76b0821b18c",
"SPAN:a550c4dabbbaf2757d1f3965"
] | [
"ASC2:aee974eb612030442c44f6c0"
] | [
"HYP:DCH:576d405698f20812b1b33e6b"
] | {"qa_id":"QA:723b0496ee2f2848910a6dea","qa_group_id":"QAG:ea7fd8c93c95684adc7efc50","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"Pdx-1-Cre (KPC) mice showed that ETS2 expression initially increas... |
QA:75a8757f8de4fe00eed3234a | QAG:0d334f8d5095e11de87d07f4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "These cells have previously been characterized for their ability to eliminate tumor cells during pancreatic cancer development and progression , and patients who have increased CD8-positive populations have improved prognosis"? Return the original wording with paper, C... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ad503e65204381ca150a049b","quotes":["These cells have previously been characterized for their ability to eliminat... | [
"CLM:ad503e65204381ca150a049b",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5031867"
] | [
"SPAN:9ff560394ba8d72d1e16e794"
] | [] | [] | {"qa_id":"QA:75a8757f8de4fe00eed3234a","qa_group_id":"QAG:0d334f8d5095e11de87d07f4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"These cells have previously been characterized for their ability t... |
QA:778c192d6a12793a64bc258e | QAG:fc896815021d28a61e192adc | provenance_qa | exact_evidence_retrieval | provenance_qa | G017 | en | train | Which exact source passage supports the statement "In the present study, Mang-NPs inhibited pancreatic cancer cell growth and CSC characteristics in vitro , and tumor growth, development and metastasis in KPC mice"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d261d4147955039fa698a231","quotes":["In the present study, Mang-NPs inhibited pancreatic cancer cell growth and C... | [
"CLM:d261d4147955039fa698a231",
"CLM:001c7a79ecd0dfbb4975d549"
] | [
"PMCID:PMC5021984"
] | [
"SPAN:7f3984cda505f8e3e2e906aa"
] | [] | [] | {"qa_id":"QA:778c192d6a12793a64bc258e","qa_group_id":"QAG:fc896815021d28a61e192adc","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G017","question":"Which exact source passage supports the statement \"In the present study, Mang-NPs inhibited pancreatic cancer cell gr... |
QA:7bad74341d4dd34ee79fda95 | QAG:3a284c615cb8356c5d95b00d | provenance_qa | paper_evidence_availability | provenance_qa | G017 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6962494? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC6962494","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC6962494"
] | [] | [] | [] | {"qa_id":"QA:7bad74341d4dd34ee79fda95","qa_group_id":"QAG:3a284c615cb8356c5d95b00d","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G017","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6962494... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.